Back
Golden Matrix Group Vs. Summit Therapeutics Industry Stock Comparison
Sell
19
GMGI
Golden Matrix Group
Last Price:
$2.04
Seasonality Move:
87.48%
Sell
48
SMMT
Summit Therapeutics
Last Price:
$19.03
Seasonality Move:
17.04%
Sell
19
Golden Matrix Group (GMGI)
is a Sell
Is Golden Matrix Group a Buy, Sell or Hold?
-
The current Golden Matrix Group [GMGI] share price is $2.04. The Score for GMGI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
GMGI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $19.03. The Score for SMMT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GMGI Stock Price Chart
What is Golden Matrix Group's stock price today?
-
The Golden Matrix Group share price today is $2.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMGI is experiencing selling pressure, which indicates risk of future bearish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $19.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
GMGI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 46.16 | Sell |
Chaikin Money Flow: | -73475 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.94 - 2.16) | Sell |
Bollinger Bands (100): | (2.09 - 2.55) | Sell |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 54.1 | Buy |
Chaikin Money Flow: | 834162 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.6 - 18.8) | Buy |
Bollinger Bands (100): | (16.03 - 22.61) | Sell |
GMGI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.14 | Sell |
20-day SMA: | 2.06 | Sell |
50-day SMA: | 2.28 | Sell |
200-day SMA: | 2.8 | Sell |
8-day EMA: | 2.14 | Sell |
20-day EMA: | 2.12 | Sell |
50-day EMA: | 2.2 | Sell |
200-day EMA: | 2.54 | Sell |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.13 | Buy |
20-day SMA: | 18.16 | Buy |
50-day SMA: | 18.72 | Buy |
200-day SMA: | 13.25 | Buy |
8-day EMA: | 18.21 | Buy |
20-day EMA: | 18.22 | Buy |
50-day EMA: | 18.47 | Buy |
200-day EMA: | 14.37 | Buy |
Golden Matrix Group Earnings Growth & GMGI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.
Golden Matrix Group Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |